Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 3
Submit an article Journal homepage
805
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study

Lina LindströmCentre for Digestive Diseases, Division of Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Correspondence[email protected]
View further author information
,
Kristin K. JørgensenDepartment of Transplantation Medicine, Section for Gastroenterology and Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; ;Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; View further author information
,
Kirsten M. BobergDepartment of Transplantation Medicine, Section for Gastroenterology and Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; ;Institute of Clinical Medicine, University of Oslo, Oslo, Norway; View further author information
,
Maria CastedalTransplant Institute, Sahlgrenska University Hospital and Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; View further author information
,
Allan RasmussenDepartment of Surgery and Liver Transplantation, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Andreas Arendtsen RostvedDepartment of Surgery and Liver Transplantation, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Helena IsoniemiDepartment of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; View further author information
,
Matteo BottaiUnit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenView further author information
&
Annika BergquistCentre for Digestive Diseases, Division of Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; View further author information
 show all
Pages 297-304 | Received 21 Sep 2017, Accepted 18 Dec 2017, Published online: 04 Jan 2018

References

  • Melum E. Nordic Liver Transplant Registry (NLTR), in Annual Report 2015; 2015.
  • Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol. 2012;18:1–15.
  • Hildebrand T, Pannicke N, Dechene A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transpl. 2016;22:42–52.
  • Ravikumar R, Tsochatzis E, Jose S, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol. 2015;63:1139–1146.
  • Montano-Loza AJ, Bhanji RA, Wasilenko S, et al. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2017;45:485–500.
  • Alabraba E, Nightingale P, Gunson B, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009;15:330–340.
  • Jrgensen KK, Grzyb K, Lundin KEA, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536–545.
  • Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615.
  • de Vries AB. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 2015;21:1956–1971.
  • Jørgensen KK, Lindström L, Cvancarova M, et al. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:517–523.
  • Alexander J, Lord JD, Yeh MM, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14:245–251.
  • Kugelmas M. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2003;9:727–732.
  • Tamura S, Sugawara Y, Kaneko J, et al. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int. 2007;27:86–94.
  • Ravikumar R, Tsochatzis E, Jose S, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol. 2015;63:1139–1146.
  • Egawa H, Taira K, Teramukai S, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience. Dig Dis Sci. 2009;54:1347–1354.
  • Jeyarajah DR, Netto GJ, Lee SP, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation – is chronic rejection part of the disease process?. Transplantation. 1998;66:1300–1306.,
  • Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870–877.
  • Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis. 1991;11:31–39.
  • Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology. 1999;29:1050–1056.
  • Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–678.
  • Egawa H, Ueda Y, Ichida T, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transplant. 2011;11:518–527.
  • Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017;152:1975–1984 e8.
  • Dmitrewski J, Hubscher SG, Mayer AD, et al. Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J Hepatol. 1996;24:253–257.
  • Montano-Loza AJ, Wasilenko S, Bintner J, et al. Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant. 2010;10:852–858.
  • Scott LJ, McKeage K, Keam SJ, et al. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs. 2003;63:1247–1297.
  • Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006; p. CD005161.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.